Skip to main content
See every side of every news story
Published loading...Updated

Popular Analysis Technique Hides Patient Variability in Alzheimer's Drug Trials

Researchers said the method can turn weak amyloid-cognition signals into strong ones and made a failed solanezumab trial appear positive.

Summary by News Medical
A statistical approach being used to support a new class of Alzheimer's drugs may lead to overstated claims about how the drugs work, according to a new study led by researchers at the Brown University School of Public Health.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Neuroscience News broke the news on Monday, May 18, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal